Qiao Wei, Ren Xiaoqi, Shi Hao, Li Jing, Yang Ting, Ma Shaoying, Zhao Yaping, Su Chengzhong, Li Baoxing
Shanxi Province Tissue Bank of China Institute for Radiation Protection, Shanxi Osteorad Biomaterial Co. Ltd, Taiyuan Shanxi, 030006, P.R.China.
Shanxi Province Tissue Bank of China Institute for Radiation Protection, Shanxi Osteorad Biomaterial Co. Ltd, Taiyuan Shanxi, 030006,
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Oct 15;31(10):1250-1255. doi: 10.7507/1002-1892.201705001.
To investigate the biocompatibility of true bone ceramic (TBC) and provide experimental basis for clinic application.
TBC was prepared from healthy adult bovine cancellous bone by deproteinization and high temperature calcinations. Mouse fibroblast cell line (L929 cells) were cultured with the leaching liquor of TBC , and the cytotoxicity was evaluated at 2nd, 4th, and 7th days. L929 cells were inoculated into the TBC and cultured for 4 days. The cell adhesion and proliferation on the surface of the TBC were observed by scanning electron microscopy, and evaluated the cell compatibility of TBC. Ten New Zealand white rabbits were divided into 2 groups, and drilled holes at the tibia of both hind limbs. TBC and hydroxyapatite (HA) were implanted into the left side (experimental group) and the right side (control group), respectively. And the biocompatibility of TBC was evaluated by general observation and histological observation at 4 and 26 weeks after implantation.
Cytotoxicity test showed that the cytotoxicity level of leaching liquor of TBC was grade 0-1. Cell compatibility experiments showed that the L929 cells adhered well on the surface of TBC and migrated into the pores. The implantation test showed that experimental group and control group both had mild or moderate inflammatory response at 4 weeks, and new bone formation occurred. At 26 weeks, there was no inflammatory reaction observed in both groups, and new bone formation was observed in varying degrees.
TBC have good biocompatibility and can be used to repair bone defect in clinic.
研究真骨陶瓷(TBC)的生物相容性,为临床应用提供实验依据。
采用去蛋白和高温煅烧法从健康成年牛松质骨制备TBC。用TBC浸出液培养小鼠成纤维细胞系(L929细胞),并在第2、4和7天评估细胞毒性。将L929细胞接种到TBC上培养4天。通过扫描电子显微镜观察TBC表面的细胞黏附和增殖情况,评估TBC的细胞相容性。将10只新西兰白兔分为2组,在双侧后肢胫骨钻孔。分别将TBC和羟基磷灰石(HA)植入左侧(实验组)和右侧(对照组)。并在植入后4周和26周通过大体观察和组织学观察评估TBC的生物相容性。
细胞毒性试验表明,TBC浸出液的细胞毒性等级为0-1级。细胞相容性实验表明,L929细胞在TBC表面黏附良好并迁移至孔隙内。植入试验表明,实验组和对照组在4周时均有轻度或中度炎症反应,并有新骨形成。在26周时,两组均未观察到炎症反应,且均有不同程度的新骨形成。
TBC具有良好的生物相容性,可用于临床修复骨缺损。